As of Jul 22
| +0.02 / +0.22%|
The 6 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 10.00. The median estimate represents a +7.41% increase from the last price of 9.31.
The current consensus among 7 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.